- Home
- IINN vs ABP Comparison
IINN vs ABP Comparison
Compare IINN & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- ABP
- Stock Information
- Founded
- IINN 2018
- ABP 2004
- Country
- IINN Israel
- ABP United States
- Employees
- IINN N/A
- ABP N/A
- Industry
- IINN Medical/Dental Instruments
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- ABP Health Care
- Exchange
- IINN Nasdaq
- ABP Nasdaq
- Market Cap
- IINN 13.7M
- ABP 15.5M
- IPO Year
- IINN 2021
- ABP N/A
- Fundamental
- Price
- IINN $0.73
- ABP $0.21
- Analyst Decision
- IINN Strong Buy
- ABP Strong Buy
- Analyst Count
- IINN 1
- ABP 1
- Target Price
- IINN $2.00
- ABP $4.00
- AVG Volume (30 Days)
- IINN 825.5K
- ABP 28.3M
- Earning Date
- IINN 06-13-2025
- ABP 05-15-2025
- Dividend Yield
- IINN N/A
- ABP N/A
- EPS Growth
- IINN N/A
- ABP N/A
- EPS
- IINN N/A
- ABP N/A
- Revenue
- IINN N/A
- ABP $183,000.00
- Revenue This Year
- IINN N/A
- ABP N/A
- Revenue Next Year
- IINN N/A
- ABP N/A
- P/E Ratio
- IINN N/A
- ABP N/A
- Revenue Growth
- IINN N/A
- ABP 88.66
- 52 Week Low
- IINN $0.40
- ABP $0.15
- 52 Week High
- IINN $2.17
- ABP $11.19
- Technical
- Relative Strength Index (RSI)
- IINN 66.69
- ABP N/A
- Support Level
- IINN $0.53
- ABP N/A
- Resistance Level
- IINN $0.80
- ABP N/A
- Average True Range (ATR)
- IINN 0.08
- ABP 0.00
- MACD
- IINN 0.03
- ABP 0.00
- Stochastic Oscillator
- IINN 81.36
- ABP 0.00
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.